Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
A Phase II Study Evaluating the Efficacy and Safety of Pembrolizumab in Combination With Chemotherapy as Neoadjuvant Therapy for Triple-negative Breast Cancer
ClinicalTrials.gov study NCT05681728. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05809895. IPD Sharing: YES. Countries: 0. Publications: 0.
A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT05227664. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Patterns of Care and Outcomes in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT07092254. IPD Sharing: NO. Countries: 0. Publications: 0.
Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01514565. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapy
ClinicalTrials.gov study NCT07357948. IPD Sharing: YES. Countries: 0. Publications: 0.
Anthracycline-Free Neoadjuvant Chemoimmunotherapy for Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT06845319. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04083963. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer
ClinicalTrials.gov study NCT04159142. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02593227. IPD Sharing: NO. Countries: 1. Publications: 0.
Talazoparib Maintenance Therapy in Triple-negative Breast Cancer
ClinicalTrials.gov study NCT04755868. IPD Sharing: NO. Countries: 1. Publications: 0.
FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06519370. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT06685796. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03971409. IPD Sharing: NO. Countries: 1. Publications: 0.
Investigating Datopotamab Deruxtecan Plus Durvalumab Versus Datopotamab Deruxtecan in Patients With PDL1-negative Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06954480. IPD Sharing: Not stated. Countries: 1. Publications: 0.
JS207 Combination Therapy in Triple-negative Breast Cancer
ClinicalTrials.gov study NCT07045311. IPD Sharing: NO. Countries: 1. Publications: 0.
Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer
ClinicalTrials.gov study NCT02338531. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Cancer Immunotherapeutic (PCI) Strategy in Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT07300475. IPD Sharing: NO. Countries: 1. Publications: 0.
Bisphenol and Phthalate Exposures in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04268693. IPD Sharing: NO. Countries: 1. Publications: 0.
Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06355037. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.